Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Thorne

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2016
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFabHongyan Li, Bingjian Feng, Alexander Miron, et al.
Cancers|August 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 StatusJavier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, et al.
NPJ Breast Cancer|January 18, 2022
Value of the loss of heterozygosity to BRCA1 variant classificationElizabeth Santana Dos Santos, Amanda B Spurdle, Dirce M Carraro, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2021
Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)Zhoufeng Ye, Shuai Li, Gillian S Dite, et al.
Breast Cancer Research : BCR|March 2, 2006
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceGraham J Mann, Heather Thorne, Rosemary L Balleine, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2021
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancerRebeca Lozano, Daniela C Salles, Shahneen Sandhu, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|June 28, 2022
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genesAnna Sofia Trigos, Anupama Pasam, Patricia Banks, et al.
European Urology|February 13, 2018
Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International StudyJoaquin Mateo, Heather H Cheng, Himisha Beltran, et al.
Ebiomedicine|March 9, 2026
Integrating breast tumour homologous recombination deficiency status to aid germline BRCA1 and BRCA2 variant classificationCristina Fortuno, Jia Zhang, Lambros T Koufariotis, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 13, 2016
Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFabHongyan Li, Bingjian Feng, Alexander Miron, et al.
Cancers|August 26, 2022
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 StatusJavier Octavio Mejía-Hernández, Dinesh Raghu, Franco Caramia, et al.
NPJ Breast Cancer|January 18, 2022
Value of the loss of heterozygosity to BRCA1 variant classificationElizabeth Santana Dos Santos, Amanda B Spurdle, Dirce M Carraro, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 30, 2021
Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC)Zhoufeng Ye, Shuai Li, Gillian S Dite, et al.
Breast Cancer Research : BCR|March 2, 2006
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resourceGraham J Mann, Heather Thorne, Rosemary L Balleine, et al.
European Journal of Cancer (Oxford, England : 1990)|February 24, 2021
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancerRebeca Lozano, Daniela C Salles, Shahneen Sandhu, et al.
Nature Communications|June 19, 2026
Recurrent intra-tumour heterogeneity is a hallmark of metastatic prostate cancerSirui Weng, Lachlan Cain, James Comben, et al.
Pageof 5